Summary. Low levels of blood glucose and hepatic glycogen in thyroparathyroidectomized (TPTX) mothers and their fetuses have been shown to increase after vitamin D 3 metabolite injection to the mothers when their plasma calcium is low or slightly elevated. To determine the putative role of calcium in these experiments, we elevated TPTX maternal plasma calcium by calcium supplementation or dietary calcium manipulations. Four hours later, glucose administration to those mothers at day 21.5 of gestation increased hepatic glycogen concentrations as well as 14 C-glucose incorporation in hepatic glycogen in both mothers and fetuses. In contrast, the simultaneous treatment of TPTX mothers with calcium and glucose at day 21.5 of gestation induced marked elevations in fetal and maternal blood glucose levels 4 h later without changing hepatic glycogen stores. In fact, 14 C-glucose incorporation decreased in fetal liver glycogen. Similar results were obtained in chronic experiments involving calcium supplementation with calcium lactate or the use of a calcium-rich diet. Blood glucose levels were normalized, whereas hepatic glycogen levels were unchanged in both mothers and fetuses. On the contrary, the use of a low phosphorus diet (known to increase 1,25-dihydroxyvitamin D 3 production) in TPTX mothers increased both blood glucose and hepatic glycogen concentrations in mothers and fetuses. These data suggest that 1,25-dihydroxyvitamin D 3 in TPTX mothers may act in two ways : (i) by increasing plasma calcium which would partly explain the normoglycemia, and (ii) by inhibiting the glycogenolytic effect of calcium and thus allowing hepatic glycogen stores to increase Introduction.
Rat fetuses from thyroparathyroidectomized (TPTX) mothers are known to exhibit decreased values of blood glucose and hepatic glycogen stores (Porterfield, Whittle and Hendrich, 1975 ; Garel and Gilbert, 1978) , and grafting one parathyroid gland or injecting vitamin D 3 metabolites to TPTX mothers restores those levels in the fetus (Gilbert, Besnard and Garel, 1980) . This increase in both the fetal blood glucose and the liver glycogen stores occurs in the presence of a low but slightly elevated level of maternal plasma calcium (Garel, Gilbert and Besnard, 1981 (1976) . The frozen liver was weighed and homogenized (2.5 p. 100) in bi-distilled water with a glass teflon homogenizer. 0.1 ml of homogenate was spotted on a 2 X 3-cm piece of filter paper (Whatman 3 MM chromatography paper). The papers were dropped into a beaker containing 66 p. 100 ethanol and washed 3 times (3 X 10 min). They were then rinsed briefly with acetone, dried and placed in plastic tubes containing 0.4 ml of acetate buffer (0.05 M, pH 4.5), 1.6 ml of H 2 0 and 0.2 ml of amylo «-1,4/«-1,6 glucosidase (3 units). The tubes were put at 55 °C for 30 min to allow the glycogen to hydrolize. Glucose was determined in 0.1 ml of hydrolysate using the glucose oxidase method. One ml of hydrolysate was placed in a vial containing 10 ml of scintillation liquid (PCS Amersham Searle) and radioactivity was measured in a liquid scintillation spectrometer (Nuclear Chicago Corp., Des Plaines, IIL).
The results, statistically analyzed using Student's unpaired t-test to determine the significance of changes between the control and the experimental groups, were recorded as the mean + SEM.
Results.
-Glucose or calcium administration to TPTX mothers. fig. 1) , the lowest concentration occurring at 19.5 days (1.21 mg/100 ml). Blood glucose levels were normalized, but hepatic glycogen stores were not significantly increased ( fig. 1). A low phosphorus diet (0.2 p. 100 P, 1.2 p. 100 Ca) given to TPTX mothersraised both plasma calcium and blood glucose levels at 21.5 days of gestation in the mother ( fig. 1 ). Those levels were not different from the levels of the normal females. The, plasma phosphate content was sharply reduced (mean value : 1.97 ± 0.2 mg/100 ml), and the hepatic glycogen stores greatly enhanced (by 9-fold) at the same time ( fig. 1). A maternal plasma phosphate level of 0.4 ± 0.05 mg/100 ml was observed at day 20.5 of gestation.
Effects on the fetus. -Fetal weight at day 21.5 of gestation was slightly improved when the TPTX mothers were fed a calcium-rich diet (Ca/P : 3). In spite of a normal blood glucose level, the hepatic glycogen stores were not increased ( fig. 1) (Garel, Gilbert and Besnard, 1979 ; Gilbert, Besnard and Garel, 1980) . These effects are not due to the nutritional status of the mother (Gilbert, Besnard and Garel,1980) ; the fact that fetal liver glycogen stores are unchanged after maternal dietary restriction is well known. It is difficult to explain our results, but some speculation can be made. The parathyroid hormone has been shown to stimulate hepatic glucose production and gluconeogenesis in vitro and in vivo (Moxley et al.,1974 ; Hruska et al., 1979) . The effect observed in vivo is specific to the entire molecule (PTH 1-84) since the synthetic NH,-terminal tetracontapeptide (PTH 1-34) has no effect (Hruska et al., 1979) ; however both molecules are equally effective in raising plasma calcium. Thus, the high blood glucose levels occurring in our experiments after calcium treatment were probably not related to an increase in gluconeogenesis. In response to the rise in both blood calcium and glucose, the reduced circulating levels of insulin probably increased, whereas glucagon decreased. In such conditions, a glycogenic effect should be observed. However, that was not the case since 14 C-glucose incorporation decreased in the liver. Available evidence suggests that calcium enhances glycogenolysis by acting on phosphorylase, an enzyme which was shown to be calcium-sensitive in vitro (Keppens et al., 1977 ; Van de Werve et al., 1977 
